M
Minh Hong Nguyen
Researcher at University of Pittsburgh
Publications - 40
Citations - 3987
Minh Hong Nguyen is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Lung transplantation & Echinocandin. The author has an hindex of 18, co-authored 40 publications receiving 3481 citations. Previous affiliations of Minh Hong Nguyen include Georgetown University Medical Center.
Papers
More filters
Journal ArticleDOI
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
John R. Perfect,William E. Dismukes,Françoise Dromer,David L. Goldman,John R. Graybill,Richard J. Hamill,Thomas S. Harrison,Robert A. Larsen,Olivier Lortholary,Olivier Lortholary,Minh Hong Nguyen,Peter G. Pappas,William G. Powderly,Nina Singh,Jack D. Sobel,Tania C. Sorrell +15 more
TL;DR: Emphasis has been placed on potential complications in management of cryptococcal infection, including increased intracranial pressure, immune reconstitution inflammatory syndrome (IRIS), drug resistance, and cryptococcomas.
Journal ArticleDOI
Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance.
TL;DR: The prevalence and variables associated with compliance with antiretroviral therapy in patients with human immunodeficiency virus infection, by means of a longitudinal observational study of 46 patients aged 23 to 68 years, are assessed.
Journal ArticleDOI
Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteremia: Findings of a Multicenter Prospective Observational Trial
Minh Hong Nguyen,Victor L. Yu,Arthur J. Morris,L. A. McDermott,Marilyn W. Wagener,Lizzie Harrell,David R. Snydman +6 more
TL;DR: In vitro activity of agents directed at Bacteroides species reliably predicts outcome: the specificity was 97%, and positive predictive value was 82%.
Journal ArticleDOI
Colistin-Resistant, Klebsiella pneumoniae Carbapenemase (KPC)–Producing Klebsiella pneumoniae Belonging to the International Epidemic Clone ST258
Tatiana Bogdanovich,Jennifer M. Adams-Haduch,Guo Bao Tian,Guo Bao Tian,Minh Hong Nguyen,Eun J. Kwak,Carlene A. Muto,Yohei Doi +7 more
TL;DR: Five cases of infection due to colistin-resistant, Klebsiella pneumoniae carbapenemase-producing K. pneumoniae belonging to the international epidemic clone ST258 occurred over a 4-month period and likely represented both emergence of resistance and transmission of resistant organism.
Journal ArticleDOI
MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting
Luis Ostrosky-Zeichner,Shmuel Shoham,Jose A. Vazquez,Annette C. Reboli,Robert F. Betts,Michelle A. Barron,Mindy G. Schuster,Marc A. Judson,Sanjay G. Revankar,Juan Pablo Caeiro,Julie E. Mangino,David M. Mushatt,Roger Bedimo,Alison G. Freifeld,Minh Hong Nguyen,Carol A. Kauffman,William E. Dismukes,Andrew O. Westfall,Jeanna Beth Deerman,Craig A. Wood,Jack D. Sobel,Peter G. Pappas +21 more
TL;DR: Caspofungin was safe and tended to reduce the incidence of invasive candidiasis when used for prophylaxis, but the difference was not statistically significant and a preemptive therapy approach deserves further study.